Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' MICHALLET M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 109 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Voog, E; Le, QL; Philip, I; Benetaib, B; Michallet, M; Fiere, D; Thomas, X
      Autologous transplantation in acute myeloid leukemia: peripheral blood stem cell harvest after mobilization in steady state by granulocyte colony-stimulating factor alone

      ANNALS OF HEMATOLOGY
    2. Bosi, A; Laszlo, D; Labopin, M; Reffeirs, J; Michallet, M; Gluckman, E; Alessandrino, PE; Locatelli, F; Vernant, JP; Sierra, J; Jouet, JP; Frassoni, F
      Second allogeneic bone marrow transplantation in acute leukemia: Results of a survey by the European Cooperative Group for Blood and Marrow Transplantation

      JOURNAL OF CLINICAL ONCOLOGY
    3. Michallet, M; Bilger, K; Garban, F; Attal, M; Huyn, A; Blaise, D; Milpied, N; Moreau, P; Bordigoni, P; Kuentz, M; Sadoun, A; Cahn, JY; Socie, G; Thomas, X; Arnaud, P; Raus, N; Lheritier, V; Pigneux, A; Boiron, JM
      Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: Impact of pretransplantation and posttransplantation factors on outcome

      JOURNAL OF CLINICAL ONCOLOGY
    4. Michallet, M
      Transplantation with selected autologous peripheral blood CD34(+)Thyl(+) hematopoietic stem cells in multiple myeloma: The issue of safety - Reply

      EXPERIMENTAL HEMATOLOGY
    5. Eljaafari, A; Farre, A; Duperrier, K; Even, J; Vie, H; Michallet, M; Souillet, G; Freidel, AC; Gebuhrer, L; Rigal, D
      Generation of helper and cytotoxic CD4+T cell clones specific for the minor histocompatibility antigen H-Y, after in vitro priming of human T cells by HLA-identical monocyte-derived dendritic cells

      TRANSPLANTATION
    6. Michallet, M; Dhedin, N; Michallet, AS
      Allogeneic hematopoietic stem-cell transplantation for hematological malignancies

      BULLETIN DU CANCER
    7. Gahrton, G; Svensson, H; Cavo, M; Apperley, J; Bacigalupo, A; Bjorkstrand, B; Blade, J; Cornelissen, J; de Laurenzi, A; Facon, T; Ljungman, P; Michallet, M; Niederwieser, D; Powles, R; Reiffers, J; Russell, NH; Samson, D; Schaefer, UW; Schattenberg, A; Tura, S; Verdonck, LF; Vernant, JP; Willemze, R; Volin, L
      Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres

      BRITISH JOURNAL OF HAEMATOLOGY
    8. Socie, G; Clift, RA; Blaise, D; Devergie, A; Ringden, O; Martin, PJ; Remberger, M; Deeg, HJ; Ruutu, T; Michallet, M; Sullivan, KM; Chevret, S
      Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies

      BLOOD
    9. Blaise, D; Maraninchi, D; Michallet, M; Reiffers, J; Jouet, JP; Milpied, N; Devergie, A; Attal, M; Sotto, JJ; Kuentz, M; Ifrah, N; Duriac, C; Bordigoni, P; Gratecos, N; Guilhot, F; Guyotat, D; Gluckman, E; Vernant, JP
      Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission

      BLOOD
    10. Fiere, D; Vernant, JP; Michallet, M; Degos, L; Leblond, V; Olteanu, N; Boucheix, C; Charrin, C; Varet, B; Huguet, FR; Delannoy, A; Gratecos, N; Lepage, E; Sebban, C
      Treatment of adult acute lymphoblastic leukemia long term results of a prospective study: LALA 87

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    11. Blaise, D; Attal, M; Reiffers, J; Michallet, M; Bellanger, C; Pico, JL; Stoppa, AM; Payen, C; Marit, G; Bouabdallah, R; Sotto, JJ; Rossi, JF; Brandely, M; Hercend, T; Maraninchi, D
      Randomized study of recombinant interleukin-2 after autologous bone marrowtransplantation for acute leukemia in first complete remission

      EUROPEAN CYTOKINE NETWORK
    12. Dreger, P; Michallet, M; Schmitz, N
      Stem-cell transplantation for chronic lymphocytic leukemia: The 1999 perspective

      ANNALS OF ONCOLOGY
    13. Michallet, M; Thiebaut, A; Philip, I; Charrin, C; Vigouroux, C; Thomas, X; Bilger, K; Belhabri, A; Guyotat, D; Corront, B; Salles, B; Dumontet, C; Peaud, PY; Vilque, JP; Devidas, A; Fiere, D
      Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-alpha

      LEUKEMIA
    14. Thomas, X; Troncy, J; Belhabri, A; Thiebaut, A; Bouheddou, N; Michallet, M; Fleurette, J; Pivot, C; Fiere, D; Archimbaud, E
      A double-blind randomized study evaluating the vancomycin-pefloxacin combination as a gastrointestinal tract decontaminant for the prevention of infections in patients with chemotherapy-induced neutropenia

      PRESSE MEDICALE
    15. Michallet, M; Philip, T; Philip, I; Godinot, H; Sebban, C; Salles, G; Thiebaut, A; Biron, P; Lopez, F; Mazars, P; Roubi, N; Leemhuis, T; Hanania, E; Reading, C; Fine, G; Atkinson, K; Juttner, C; Coiffier, B; Fiere, D; Archimbaud, E
      Transplantation with selected autologous peripheral blood CD34(+)Thy1(+) hematopoietic stem cells (HSCs) in multiple myeloma: Impact of HSC dose on engraftment, safety, and immune reconstitution

      EXPERIMENTAL HEMATOLOGY
    16. Michallet, M; Juttner, C
      The CD34(+)Thy1(+) cell population: Are they all stem cells? Response

      EXPERIMENTAL HEMATOLOGY
    17. Michallet, M; Thomas, X; Vernant, JP; Kuentz, M; Socie, G; Esperou-Bourdeau, H; Milpied, N; Blaise, D; Rio, B; Reiffers, J; Jouet, JP; Cahn, JY; Bourhis, JH; Lioure, B; Leporrier, M; Sotto, JJ; Souillet, G; Sutton, L; Bordigoni, P; Dreyfus, F; Tilly, H; Gratecos, N; Attal, M; Leprise, PY; Demeocq, F; Michel, G; Buzyn, A; Delmas-Marsalet, B; Bernaudin, F; Ifrah, N; Sadoun, A; Guyotat, D; Cavazzana-Cavo, M; Caillot, D; De Revel, T; Vannier, JP; Baruchel, A; Fegueux, N; Tanguy, ML; Thiebaut, A; Belhabri, A; Archimbaud, E
      Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM)

      BONE MARROW TRANSPLANTATION
    18. Michallet, M; Thiebaut, A; Dreger, P; Remes, K; Milpied, N; Santini, G; Hamon, M; Bjorkstrand, B; Kimby, E; Belhabri, A; Tanguy, ML; Apperley, JF
      Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalfof the EBMT Chronic Leukaemias Working Party (CLWP)

      BRITISH JOURNAL OF HAEMATOLOGY
    19. Michallet, M; Tanguy, ML; Socie, G; Thiebaut, A; Belhabri, A; Milpied, N; Reiffers, J; Kuentz, M; Cahn, JY; Blaise, D; Demeocq, F; Jouet, JP; Michallet, AS; Ifrah, N; Vilmer, E; Molina, L; Michel, G; Lioure, B; Cavazzana-Calvo, M; Pico, JL; Sadoun, A; Guyotat, D; Attal, M; Cure, H; Bordigoni, P; Sutton, L; Buzyn-Veil, A; Tilly, M; Leporrier, M; Fegueux, N; Dreyfus, F; Rio, B; Lutz, P; Vernant, JP
      Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)

      BRITISH JOURNAL OF HAEMATOLOGY
    20. Guardiola, P; Pasquini, R; Dokal, I; Ortega, JJ; van Weel-Sipman, M; Marsh, JCW; Ball, SE; Locatelli, F; Vermylen, C; Skinner, R; Ljungman, P; Miniero, R; Shaw, PJ; Souillet, G; Michallet, M; Bekassy, AN; Krivan, G; Di Bartolomeo, P; Heilmann, C; Zanesco, L; Cahn, JY; Arcese, W; Bacigalupo, A; Gluckman, E
      Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation

      BLOOD
    21. Belhabri, A; Thomas, X; Troncy, J; Assouline, D; Michallet, M; Wattel, E; Tigaud, JD; Blanc, M; Fiere, D; Archimbaud, E
      Continuous-infusion carboplatin in combination with idarubicin or mitoxantrone for high-risk acute myeloid leukemia: a randomised phase II study

      LEUKEMIA & LYMPHOMA
    22. Romand, F; Michallet, M; Pichoud, C; Trepo, C; Zoulim, F
      Hepatitis B virus reactivation after allogeneic bone marrow transplantation in a patient previously immunized against HBV

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    23. Michallet, M; Perrin, MC; Belhabri, A; Molina, L; Nicolini, F; Tigaud, JD; Sotto, JJ; Guyotat, D; Fiere, D; Archimbaud, E
      Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    24. Dhedin, N; Giraudier, S; Gaulard, P; Esperou, H; Ifrah, N; Michallet, M; Milpied, N; Rio, B; Cahn, JY; Molina, L; Laporte, JL; Guilhot, F; Kuentz, M
      Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database

      BRITISH JOURNAL OF HAEMATOLOGY
    25. MICHALLET M; THIEBAUT A
      CHEMOTHERAPY, INTERFERON AND GROWTH-FACTORS IN THE SELECTION OF NEGATIVE PHILADELPHIA CELLS

      HEMATOLOGY AND CELL THERAPY
    26. Maraninchi, D; Vey, N; Viens, P; Stoppa, AM; Archimbaud, E; Attal, M; Baume, D; Bouabdallah, R; Demeoq, F; Fleury, J; Michallet, M; Olive, D; Reiffers, J; Sainty, D; Tabilio, A; Tiberghien, P; Brandely, M; Hercend, T; Blaise, D
      A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia

      LEUKEMIA & LYMPHOMA
    27. ELJAAFARI A; DUPERRIER K; FARRE A; PHOTHIRATH P; LABONNE MP; FREIDEL AC; MICHALLET M; BETUEL H; GEBUHRER L; RIGAL D
      GENERATION OF CD4-CELL LINES SPECIFIC FOR MINOR HISTOCOMPATIBILITY ANTIGENS, BY THE USE OF MONOCYTE-DERIVED DENDRITIC CELLS( T)

      Journal of leukocyte biology
    28. MICHALLET M; FIERE D
      IN MEMORY OF ARCHIMBAUD,ERIC

      Bone marrow transplantation
    29. MICHALLET M; PERSAT F; KRANZHOFER N; LEVRON JC; PRAT C; BELHABRI A; CHWETZOFF E; LEMOING JP; FIERE D; PIENS MA
      PHARMACOKINETICS OF ITRACONAZOLE ORAL SOLUTION IN ALLOGENEIC BONE-MARROW TRANSPLANT PATIENTS RECEIVING TOTAL-BODY IRRADIATION

      Bone marrow transplantation
    30. BLAISE D; JOURDAN E; FEGUEUX N; MICHALLET M; REIFFERS J; JOUET JP; FAUCHER C; FORTANIER C; SCHULLER MP; BADRI N; CHABANNON C; MARANINCHI D
      IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION OVER THE AGE OF 45

      Bone marrow transplantation
    31. BLAISE D; JOURDAN E; FEGUEUX N; MICHALLET M; REIFFERS J; JOUET JP; MICHEL G; FAUCHER C; FORTANIER C; SCHULLER MP; BADRI N; CHABANNON C; MARANINCHI D
      IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION IN A POPULATION OF STANDARDRISK PATIENT

      Bone marrow transplantation
    32. MICHALLET M; TANGUY ML; BELHABRI A; JOUET JP; FOULON N; MICHALLET AS; VERNANT JP
      RETRANSPLANTATION FOR RELAPSE AFTER FIRST ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REPORT OF 167 CASES FOR THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM)

      Bone marrow transplantation
    33. ARCHIMBAUD E; PHILIP I; COIFFIER B; MICHALLET M; SALLES G; SEBBAN C; ROUBI N; LOPEZ F; BESSUEILLE L; MAZARS P; GERARD C; HANANIA E; RAMANATHAN R; READING C; JUTTNER C; ATKINSON K; PHILIP T
      SELECTED AUTOLOGOUS PERIPHERAL-BLOOD CD34-1+ LIN- HEMATOPOIETIC STEM-CELL (HSC) TRANSPLANTATION IN MULTIPLE-MYELOMA (MM)( THY)

      Bone marrow transplantation
    34. BLAISE D; JOURDAN E; FEGUEUX N; MICHALLET M; REIFFERS J; JOUET JP; MICHEL G; FAUCHER C; FORTANIER C; SCHULLER MP; BADRI N; CHABANNON C; MARANINCHI D
      IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION IN A POPULATION OF STANDARDRISK PATIENT

      Bone marrow transplantation
    35. THIEBAUT A; MICHALLET M; GEBUHRER L; LASNE Y; CHARRIN C; MOLLET I; BELHABRI A; ARCHIMBAUD E
      DONOR LYMPHOCYTE INFUSIONS (DLI) FOR RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - HEMATOLOGIC, CYTOGENETIC AND MOLECULAR RESULTS

      Bone marrow transplantation
    36. MICHALLET M; VANBIEZEN A; BANDINI G; CARRERAS E; CORNELISSEN JJ; DREGER P; EINSELE H; GRATWHOL A; KIMBY E; NIEDERWIESER D; APPERLEY J
      HEMATOPOIETIC STEM-CELL TRANSPLANTATIONS FOR CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)

      Bone marrow transplantation
    37. BELHABRI A; MICHALLET M; THIEBAUT A; PHILIP I; CHARRIN C; FIERE D; ARCHIMBAUD E
      AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOCYTIC-LEUKEMIA (CML) WITH PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) MOBILIZED BY G-CSF (FILGRASTIM) AND INTERFERON-ALPHA (IFN)

      Bone marrow transplantation
    38. GAHRTON G; TURA S; SVENSSON H; LJUNGMAN P; BLADE J; BJORKSTRAND B; CAVO M; FACON T; GRATWOHL A; CORNELISSEN JJ; DELAURENZI A; VANLINT M; MICHALLET M; NIKOSKELAINEN J; REIFFERS J; SAMSON D; SCHATTENBERG A; VERDONCK L; VOLIN L; APPERLEY J
      ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MULTIPLE-MYELOMA

      Bone marrow transplantation
    39. Blaise, D; Jourdan, E; Michallet, M; Jouet, JP; Boiron, JM; Michel, G; Faucher, C; Fegueux, N; Schuller, MP; Badri, N; Chabannon, C; Maraninchi, D
      Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot study

      BONE MARROW TRANSPLANTATION
    40. Cogoluenhes, VC; Chambrier, C; Michallet, M; Gordiani, B; Ranchere, JY; Combret, D; Lallemand, Y; Roldan, M; Accominoti, M; Philip, I; Latour, JF; Hulewitz, G; Biron, P; Barbieux, A; Bachmann, P
      Energy expenditure during allogeneic and autologous bone marrow transplantation

      CLINICAL NUTRITION
    41. MICHALLET M; VANBIEZEN A; BANDINI G; CARRERAS E; CORNELISSEN JJ; DREGER P; EINSELE H; GRATWOHL A; KIMBY E; NIEDWIESER D; APPERLEY J
      HEMATOPOIETIC STEM-CELL TRANSPLANTATIONS FOR CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)

      British Journal of Haematology
    42. GUILHOT F; MALOISEL F; GUERCI A; MICHALLET M; HAROUSSEAU JL; BRIERE J; ROCHANT H; CIURANA AJ; ABGRALL JF; GUYOTAT D; CHRISTIAN B; ORFEUVRE H
      UPDATE OF THE 810 CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH INTERFERON-ALPHA-2B OR IFN ALPHA-2B AND CYTARABINE

      British Journal of Haematology
    43. THIEBAUT A; MICHALLET M; GEBUHRER L; LASNE Y; CHARRIN C; MOLLET I; BELHABRI A; ARCHIMBAUD E
      DONOR LYMPHOCYTE INFUSIONS (DLI) FOR RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - HEMATOLOGIC, CYTOGENETIC AND MOLECULAR RESULTS

      British Journal of Haematology
    44. BLAISE D; JOURDAN E; FEGUEUX N; MICHALLET M; REIFFERS J; JOUET JP; MICHEL G; FAUCHER C; FORTANIER C; HUA A; SCHULLER MP; BADRI N; CHABANNON C; MARANINCHI D
      LENOGRASTIM AS A PRIMING AGENT FOR ALLOGENEIC STEM-CELL TRANSPLANTATION

      Experimental hematology
    45. MICHALLET M; JAVAUX F; GEBUHRER L; BELHABRI A; BOUHEDDOU N; CHARRIN C; LASNE Y; FIERE D; ARCHIMBAUD E
      COMPARISON BETWEEN CYTOGENETIC AND MOLECULAR STUDIES (CHIMERISM AND MINIMAL RESIDUAL DISEASE) FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - INTEREST FOR STRATEGY AFTER RELAPSE POSTTRANSPLANT

      Experimental hematology
    46. GUILHOT F; GUERCI A; MALOISEL F; MICHALLET M; HAROUSSEAU JL; BOUABDALLAH R; GUYOTAT D; ABGRALL JF; IFRAH N; BRIERE J; TERTIAN G; BAUTERS F; NAVARRO M; MORICE P; CHRISTINA B; VILQUE JM; BLANC M; CHASTANG C
      RELATIONSHIP BETWEEN CYTOGENETIC RESPONSE AND SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA - RESULTS OF 2 MULTICENTRIC TRIALS

      Experimental hematology
    47. ARCHIMBAUD E; MICHALLET M; PHILIP L; CHARRIN C; CLAPISSON G; BELHABRI A; GUILHOT F; STRYCKMANS P; ADELEINE P; FIERE D
      G-CSF (FILGRASTIM) ADMINISTERED IN ADDITION TO INTERFERON-ALPHA (IF) TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS (PBSC) FOR AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA (CML)

      Experimental hematology
    48. VANRHEE F; SZYDLO RM; HERMANS J; DEVERGIE A; FRASSONI F; ARCESE W; DEWITTE T; KOLB HJ; NIEDERWISER D; JACOBSEN N; GAHRTON G; BANDINI G; CARRERAS E; BACIGALUPO A; MICHALLET M; RUUTU T; REIFFERS J; GOLDMAN JM; APPERLEY J; GRATWOHL A
      LONG-TERM RESULTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - A REPORT FROM THE CHRONIC LEUKEMIA WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION

      Bone marrow transplantation
    49. JOURDAN E; MARANINCHI D; REIFFERS J; GLUCKMAN E; RIO B; JOUET JP; MICHALLET M; MOLINA L; ARCHIMBAUD E; HAROUSSEAU JL; IFRAH N; ATTAL M; GUILHOT F; KUENTZ M; GUYOTAT D; PICO JL; DAURIAC C; LEGROS M; DREYFUS F; BORDIGONI P; LEBLOND V; GRATECOS N; VARET B; AUZANNEAU C; TILLY H; VILMER E; BARDOU VJ; BLAISE D
      EARLY ALLOGENEIC TRANSPLANTATION FAVORABLY INFLUENCES THE OUTCOME OF ADULT PATIENTS SUFFERING FROM ACUTE MYELOID-LEUKEMIA

      Bone marrow transplantation
    50. GUILHOT F; CHASTANG C; MICHALLET M; GUERCI A; HAROUSSEAU JL; MALOISEL F; BOUABDALLAH R; GUYOTAT D; CHERON N; NICOLINI F; ABGRALL JF; TANZER J
      INTERFERON ALFA-2B COMBINED WITH CYTARABINE VERSUS INTERFERON ALONE IN CHRONIC MYELOGENOUS LEUKEMIA

      The New England journal of medicine
    51. ARCHIMBAUD E; MICHALLET M; PHILIP I; CHARRIN C; CLAPISSON G; BELHABRI A; GUILHOT F; STRYCKMANS P; ADELEINE P; FIERE D
      GRANULOCYTE-COLONY-STIMULATING FACTOR GIVEN IN ADDITION TO INTERFERON-ALPHA TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS FOR AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA

      British Journal of Haematology
    52. SOCIE G; CAHN JY; CARMELO J; VERNANT JP; JOUET JP; IFRAH N; MILPIED N; MICHALLET M; LIOURE B; PICO JL; WITZ F; MOLINA L; FISCHER A; BARDOU VJ; GLUCKMAN E; REIFFERS J
      AVASCULAR NECROSIS OF BONE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - ANALYSIS OF RISK-FACTORS FOR 4388 PATIENTS BY THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM)

      British Journal of Haematology
    53. DHEDIN CN; GIRAUDIER S; ESPEROU H; MICHALLET M; IFRAH N; RIO B; CAHN JY; SUTTON L; GAULARD P; KUENTZ M
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR AGGRESSIVE NON-HODGKIN-LYMPHOMA (EXCEPT LYMPHOBLASTIC AND BURKITT) - A REPORT OF THE FRENCH REGISTRY

      Blood
    54. MICHALLET M; BELHABRI A; ARCHIMBAUD E; TANGUY ML; VERNANT JP; RAFFOUX C; MARRY E; JOUET JP; GOLMARD JL
      STUDY OF 600 PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML) ENROLLED ONFRANCE-GREFFE-DE-MOELLE (FGM) REGISTRY WITH AN INTENTION TO TRANSPLANT FROM UNRELATED DONORS

      Blood
    55. MARIT G; FACON T; JOUET JP; KUENTZ M; VERNANT JP; ARCHIMBAUD E; MICHALLET M; HAROUSSEAU JL; MILPIED N; MOLINA L; SOTTO JJ; GUILHOT B; BLAISE D; ATTAL M; FABERES C; TANGUY ML; REIFFERS J
      ALLOGENEIC STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - A REPORT OF THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM)

      Blood
    56. ARCHIMBAUD E; PHILIP I; COIFFIER B; MICHALLET M; SALLES G; SEBBAN C; ROUBI N; LOPEZ F; BESSUEILLE L; MAZARS P; GERARD C; HANANIA S; RAMANATHAN R; READING C; JUTTNER C; ATKINSON K; PHILIP T
      SELECTED AUTOLOGOUS PERIPHERAL-BLOOD CD34-1+ LIN- HEMATOPOIETIC STEM-CELL (HSC) TRANSPLANTATION IN MULTIPLE-MYELOMA - A EUROPEAN STUDY( THY)

      Blood
    57. MICHALLET M; TANGUY ML; BELHABRI A; ARCHIMBAUD E; JOUET JP; FOULON N; MICHALLET AS; VERNANT JP
      RETRANSPLANTATION FOR RELAPSE AFTER FIRST ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REPORT OF 167 CASES FOR THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM)

      Blood
    58. MICHALLET M
      GRAFT-VERSUS-HOST DISEASE AND GRAFT-VERSUS-LEUKEMIA

      HEMATOLOGY AND CELL THERAPY
    59. REIFFERS J; HUGUET F; STOPPA AM; MOLINA L; MARIT G; ATTAL M; GASTAUT JA; MICHALLET M; LEPEU G; BROUSTET A; PRIS J; MARANINCHI D; HOLLARD D; FABERES C; MERCIER M; HURTELOUP P; DANEL P; TELLIER Z; BERTHAUD P
      A PROSPECTIVE RANDOMIZED TRIAL OF IDARUBICIN VS DAUNORUBICIN IN COMBINATION CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA OF THE AGE GROUP-55TO GROUP-75

      Leukemia
    60. REIFFERS J; STOPPA AM; ATTAL M; MICHALLET M; MARIT G; BLAISE D; HUGUET F; CORRONT B; CONYMAKHOUL P; GASTAUT JA; LAURENT G; MOLINA L; BROUSTET A; MARANINCHI D; PRIS J; HOLLARD D; FABERES C
      ALLOGENEIC VS AUTOLOGOUS STEM-CELL TRANSPLANTATION VS CHEMOTHERAPY INPATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION - THE BGMT-87STUDY

      Leukemia
    61. PHILIT F; CORDONNIER C; MICHALLET M; CORDIER JF
      PULMONARY COMPLICATIONS IN BONE-MARROW TR ANSPLANTATION

      Revue des maladies respiratoires
    62. BLAISE D; JOURDAN E; REIFFERS J; MICHALLET M; JOUET JP; MICHEL G; FAUCHER C; FORTANIER C; SCHULLER MP; CHABANNON C; MARANINCHI D
      ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION AFTER PRIMING WITH LENOGRASTIM - A PILOT-STUDY

      Experimental hematology
    63. BOIRON JM; CAHN JY; CARLOSTELLA C; BANDINI G; MELONI G; REMAN O; CARRERAS E; MICHALLET M; DELAURENZI A; MILPIED N; GRANENA A; FABERES C; APPERLEY J; REIFFERS J
      AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR PATIENTS WITH CHRONICMYELOID-LEUKEMIA (CML) IN FIRST CHRONIC PHASE (CP1) NOT RESPONDING TOALPHA-INTERFERON (IFN)

      Blood
    64. MICHALLET M; BELHABRI A; MOULLET I; PHILIP I; TREMISI P; CHARRIN C; FIERE D; ARCHIMBAUD E
      COMPARISON BETWEEN PERIPHERAL-BLOOD STEM-CELLS (PBSC) MOBILIZED BY G-CSF (FILGRASTIM) AND INTERFERON-ALPHA (IF) AND PBSC HARVESTED AT DIAGNOSIS FOR AUTOLOGOUS TRANSPLANT IN CHRONIC MYELOID-LEUKEMIA (CML)

      Blood
    65. GUILHOT F; CHASTANG C; GUERCI A; MICHALLET M; HAROUSSEAU JL; MALOISEL F; BRIERE J; BOUABDALLAH R; GUYOTAT D; TERTIAN G; NICOLINI F; ABGRALL JF; NAVARRO M; BLANC M; BRICE P; SIMON M; IFRAH N; ROCHANT F; VILQUE JP; DELAIN M; GUILHOT J; TANZER J
      INTERFERON ALPHA2B (IFN) AND CYTARABINE (ARA-C) SURVIVAL AND CYTOGENETIC RESPONSE IN CHRONIC LEUKEMIA (CML) - RESULTS OF A RANDOMIZED TRIAL

      Blood
    66. ARCHIMBAUD E; PHILIP I; COIFFIER B; MICHALLET M; SALLES G; SEBBAN C; ROUBI N; LOPEZ F; BESSUEILLE L; MAZARS P; JUTTNER C; ATKINSON K; PHILIP T
      CD34(-) PERIPHERAL-BLOOD STEM-CELLS (PBSC) TRANSPLANTATION AFTER HIGH-DOSE THERAPY FOR PATIENTS WITH MULTIPLE MYUELOMA()THY1(+)LIN()

      Blood
    67. BLAISE D; ROSSI JF; JOURDAN E; MICHALLET M; REIFFERS J; JOUET JP; MICHEL G; FAUCHER C; FORTANIER C; HUA A; SCHULLER MP; BADRI N; CHABANNON C; MARANINCHI D
      A PILOT-STUDY OF ALLOGENIC STEM-CELL TRANSPLANTATION AFTER PRIMING WITH LENOGRASTIM

      Blood
    68. REIFFERS J; STOPPA AM; HUGUET F; MOLINA L; MARIT G; BLAISE D; ATTAL M; MICHALLET M; CONYMAKHOUL P; GASTAUT JA; LAURENT G; CORRONT B; BOIRON JM; MARANINCHI D; PRIS J; SOTTO JJ; FABERES C
      THE ROLE OF ALLOGENEIC BONE-MARROW TRANSPLANTATION IN THE YOUNGER ADULTS WITH ACUTE MYELOID-LEUKEMIA (AML) IN FIRST REMISSION (CR-1) - A 10-YEAR EXPERIENCE OF THE BGMT GROUP

      Blood
    69. SUTTON L; CHASTANG C; RIBAUD P; JOUET JP; KUENTZ M; ATTAL M; REIFFERS J; TIGAUD JM; RIO B; DAURIAC C; LEGROS M; DREYFUS F; LIOURE B; TROUSSARD X; MILPIED N; WITZ F; ORIOL P; CAHN JY; MICHALLET M; GLUCKMAN E; IFRAH N; PICO JL; VILMER E; LEBLOND V
      FACTORS INFLUENCING OUTCOME IN DE-NOVO MYELODYSPLASTIC SYNDROMES TREATED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION - A LONG-TERM STUDY OF 71 PATIENTS

      Blood
    70. MICHALLET M; ROWLINGS PA; ROZMAN C
      ALLOGENEIC BONE-MARROW TRANSPLANTATION IN CHRONIC LYMPHOCYTIC-LEUKEMIA - RESPONSE

      Annals of internal medicine
    71. MICHALLET M; ARCHIMBAUD E; BANDINI G; ROWLINGS PA; DEEG HJ; GAHRTON G; MONTSERRAT E; ROZMAN C; GRATWOHL A; GALE RP
      HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION IN YOUNGER PATIENTSWITH CHRONIC LYMPHOCYTIC-LEUKEMIA

      Annals of internal medicine
    72. GAHRTON G; TURA S; LJUNGMAN P; BLADE J; CAVO M; DELAURENZI A; FACON T; GRATWOHL A; MICHALLET M; NIKOSKELAINEN J; PEARCE R; REIFFERS J; SAMSON D; SCHATTENBERG A; VERDONCK L; VERNANT JP; VOLIN L
      AN UPDATE OF PROGNOSTIC FACTORS FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MULTIPLE-MYELOMA USING MATCHED SIBLING DONORS

      Stem cells
    73. DASTUGUE N; PAYEN C; LAFAGEPOCHITALOFF M; BERNARD P; LEROUX D; HUGUETRIGAL F; STOPPA AM; MARIT G; MOLINA L; MICHALLET M; MARANINCHI D; ATTAL M; REIFFERS J
      PROGNOSTIC-SIGNIFICANCE OF KARYOTYPE IN DE-NOVO ADULT ACUTE MYELOID-LEUKEMIA

      Leukemia
    74. JOURDAN E; MARANINCHI D; REIFFERS J; ARCHIMBAUD E; MICHALLET M; HAROUSSEAU JL; IFRAH N; RIO B; GUYOTAT D; GUILHOT F; ATTAL M; LEBLOND V; DAURIAC C; LEGROS M; PICO JL; MARIT G; BLAISE D
      ALLOGENEIC BONE-MARROW TRANSPLANTATION REMAINS AN EFFICIENT CONSOLIDATION FOR ADULTS WITH ACUTE MYELOID-LEUKEMIA EVEN WHEN PERFORMED VERY SOON AFTER DIAGNOSIS (LESS-THAN-100 DAYS)

      Leukemia
    75. GAHRTON G; TURA S; LJUNGMAN P; BLADE J; BRANDT L; CAVO M; FACON T; GRATWOHL A; HAGENBEEK A; JACOBS P; DELAURENZI A; VANLINT M; MICHALLET M; NIKOSKELAINEN J; REIFFERS J; SAMSON D; VERDONCK L; DEWITTE T; VOLIN L
      PROGNOSTIC FACTORS IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA

      Journal of clinical oncology
    76. ARCHIMBAUD E; THOMAS X; LEBLOND V; MICHALLET M; FENAUX P; CORDONNIER C; DREYFUS F; TROUSSARD X; JAUBERT J; TRAVADE P; TRONCY J; ASSOULINE D; FIERE D
      TIMED SEQUENTIAL CHEMOTHERAPY FOR PREVIOUSLY TREATED PATIENTS WITH ACUTE MYELOID-LEUKEMIA - LONG-TERM FOLLOW-UP OF THE ETOPOSIDE, MITOXANTRONE, AND CYTARABINE-86 TRIAL

      Journal of clinical oncology
    77. ANGLARET B; THIEBAUT A; THOMAS X; MICHALLET M; FIERE D; ARCHIMBAUD E
      EFFECT OF CONTINUOUS INTRAVENOUS-INFUSION OF PENTOXIFYLLINE ON REGIMEN RELATED TOXICITY IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Experimental hematology
    78. ARCHIMBAUD E; MICHALLET M; PHILIP I; SEBBAN C; DANAILA C; FIERE D
      G-CSF (FILGRASTIM) TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS FOR AUTOLOGOUS TRANSPLANT IN CHRONIC MYELOID-LEUKEMIA

      Experimental hematology
    79. PIGNEUX A; DEVERGIE A; POCHITALOFF M; RIO B; ARCHIMBAUD E; CAHN JY; LEBLOND V; MICHALLET M; JOUET JP; GUILHOT F; GLUCKMAN E; REIFFERS J
      RECOMBINANT ALPHA-INTERFERON AS TREATMENT FOR CHRONIC MYELOGENOUS LEUKEMIA IN RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REPORT FROM THE SOCIETE-FRANCAISE-LE-GREFFE-DE-MOELLE

      Bone marrow transplantation
    80. BLAISE D; OLIVE D; MICHALLET M; MARIT G; LEBLOND V; MARANINCHI D
      IMPAIRMENT OF LEUKEMIA-FREE SURVIVAL BY ADDITION OF INTERLEUKIN-2-RECEPTOR ANTIBODY TO STANDARD GRAFT-VERSUS-HOST PROPHYLAXIS

      Lancet
    81. ATTAL M; BLAISE D; MARIT G; PAYEN C; MICHALLET M; VERNANT JP; SAUVAGE C; TROUSSARD X; NEDELLEC G; PICO J; HUGUET F; STOPPA AM; BROUSTET A; SOTTO JJ; PRIS J; MARANINCHI D; REIFFERS J
      CONSOLIDATION TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A PROSPECTIVE, RANDOMIZED TRIAL COMPARING ALLOGENEIC VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND TESTING THE IMPACT OF RECOMBINANT INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Blood
    82. GRATWOHL A; HERMANS J; APPERLEY J; ARCESE W; BACIGALUPO A; BANDINI G; DIBARTOLOMEO P; BOOGAERTS M; BOSI A; CARRERAS E; DEVERGIE A; FERRANT A; FIBBE WE; FRASSONI F; GAHRTON G; GOLDMAN J; IRIONDO A; JACOBSEN N; KOLB HJ; LINK H; MICHALLET M; PRENTICE HG; REIFFERS J; VONRHEE F; RUUTU T; SCHWAIGHOFER H; VERNANT JP; DEWITTE T; NIEDERWIESER D
      ACUTE GRAFT-VERSUS-HOST DISEASE - GRADE AND OUTCOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA

      Blood
    83. MICHALLET M; MOULLET I; ARCHIMBAUD E; TARDY JC; DHEDIN N; BELHABRI A; GUYOTAT D; TIGAUD JD; AYMARD M; FIERE D
      RETROSPECTIVE STUDY OF HEPATITIS-C VIRUS-INFECTION IN 244 PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANT (1980 TO 1993)

      Blood
    84. MICHALLET M; ARCHIMBAUD E; ROWLINGS PA; HOROWITZ MM; GRATWOHL A; GALE RP
      HEMATOPOIETIC STEM-CELL TRANSPLANT FOR CHRONIC LYMPHOCYTIC-LEUKEMIA

      Blood
    85. DEVERGIE A; BLAISE D; ATTAL M; TIGAUD JD; JOUET JP; VERNANT JP; BORDIGONI P; IFRAH N; DAURIAC C; CAHN JY; LIOURE B; TROUSSARD X; REIFFERS J; GRATECOS N; MILPIED N; BELANGER C; GUYOTAT D; TILLY H; MICHALLET M; GLUCKMAN E
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA IN FIRST CHRONIC PHASE - A RANDOMIZED TRIAL OF BUSULFAN-CYTOXAN VERSUS CYTOXAN-TOTAL-BODY IRRADIATION AS PREPARATIVE REGIMEN - A REPORT FROM THE FRENCH-SOCIETY-OF-BONE-MARROW-GRAFT (SFGM)

      Blood
    86. LEBEAU B; PELLOUX H; PINEL C; MICHALLET M; GOUT JP; PISON C; DELORMAS P; BRU JP; BRION JP; AMBROISETHOMAS P; GRILLOT R
      ITRACONAZOLE IN THE TREATMENT OF ASPERGILLOSIS - A STUDY OF 16 CASES

      Mycoses
    87. REIFFERS J; STOPPA AM; ATTAL M; MICHALLET M
      IS THERE A PLACE FOR BLOOD STEM-CELL TRANSPLANTATION FOR THE YOUNGER ADULT PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA

      Journal of clinical oncology
    88. ARCHIMBAUD E; THOMAS X; MICHALLET M; JAUBERT J; TRONCY J; GUYOTAT D; FIERE D
      PROSPECTIVE GENETICALLY RANDOMIZED COMPARISON BETWEEN INTENSIVE POSTINDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN ADULTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA

      Journal of clinical oncology
    89. SEBBAN C; LEPAGE E; VERNANT JP; GLUCKMAN E; ATTAL M; REIFFERS J; SUTTON L; RACADOT E; MICHALLET M; MARANINCHI D; DREYFUS F; FIERE D
      ALLOGENEIC BONE-MARROW TRANSPLANTATION IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION - A COMPARATIVE-STUDY

      Journal of clinical oncology
    90. DEVERGIE A; LABOPIN M; APPERLEY J; CARRERAS E; PRENTICE G; HERSTENSTEIN B; REIFFERS J; MICHALLET M; JACOBSEN N; JOUET JP; GOLDMAN J; VANBIEZEN A; GRATWOHL A
      MATCHED UNRELATED DONOR (MUD) TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA(CML) IN EUROPE - REPORT OF 299 CASES AND ANALYSIS OF PROGNOSIS FACTORS

      Experimental hematology
    91. LJUNGMAN P; BIRON P; BOSI A; CAHN JY; GOLDSTONE AH; GORIN NC; LINK H; MESSINA C; MICHALLET M; RICHARD C; VERDONCK L
      CYTOMEGALOVIRUS INTERSTITIAL PNEUMONIA IN AUTOLOGOUS BONE-MARROW TRANSPLANT RECIPIENTS

      Bone marrow transplantation
    92. REIFFERS J; FABERES C; STOPPA AM; ATTAL M; MICHALLET M
      TREATMENT OF ACUTE MYELOID-LEUKEMIA IN ADULTS - THE BGMT RESULTS

      Blood
    93. MICHALLET M; ARCHIMBAUD E; MOLINA L; PERRIN MC; BELHABRI A; GUYOTAT D; NICOLINI F; TIGAUD JD; HOLLARD D; FIERE D
      IMPACT OF GRAFT-VERSUS-HOST DISEASE PROPHYLACTIC AND THERAPEUTIC MANAGEMENT ON SURVIVAL AND DURATION OF COMPLETE REMISSION

      Blood
    94. KRANZHOFER N; MICHALLET M; GEBUHRER L; FREICHE JC; DHEDIN N; TIGAUD JD; LABONNE MP; ARCHIMBAUD E; FIERE D
      EVALUATION OF THE CHIMERIC STATE BY ENZYMATIC AMPLIFICATION OF VARIABLE NUMBER OF TANDEM REPEATS AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOLLOWING CONDITIONING REGIMEN CONTAINING EITHER TOTAL-BODY IRRADIATION OR BUSULFAN

      Blood
    95. DEVERGIE A; LABOPIN M; APPERLEY J; CARRERAS E; PRENTICE G; HERSTENSTEIN B; REIFFERS J; MICHALLET M; JACOBSEN N; JOUET JP; GOLDMAN J; VANBIEZEN A; GRATWOHL A
      EUROPEAN RESULTS OF 357 MATCHED UNRELATED DONOR (MUD) TRANSPLANTS FORCHRONIC MYELOID-LEUKEMIA (CML) - IMPACT OF HLAD SUBTYPES ANALYSIS

      Blood
    96. GRATWOHL A; HERMANS J; APPERLEY J; ARCESE W; BACIGULAPO A; BANDINI G; BOOGAERTS M; BOSI A; CARRERAS E; DEVERGIE A; FERRANT A; FIBBE WE; FRASSONI F; GAHRTON G; GOLDMAN J; IRIONDO A; JACOBSEN N; LINK H; KOLB HJ; MICHALLET M; PRENTICE HG; REIFFERS J; VANRHEE F; RUUTU T; TORLONTANO G; SCHWEIKOFER H; VERNANT JP; DEWITTE T; NIEDERWIESER D
      ACUTE GRAFT-VERSUS-HOST DISEASE - GRADE AND OUTCOME IN PATIENTS WITH CML

      Blood
    97. BLAISE D; OLIVE D; ARCHIMBAUD E; REIFFERS J; LEBLOND V; MICHALLET M; VERNANT JP; IFRAH N; BELLANGER C; ATTAL M; MILPIED N; MARIT G; GUYOTAT D; CAUDRELIER P; HIRN M; MARANINCHI D
      GVHD PROPHYLAXIS WITH AN ANTI-IL2 RECEPTOR MONOCLONAL-ANTIBODY - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL IN STANDARD RISK LEUKEMIA

      Blood
    98. JOURDAN E; BLAISC D; REIFFERS J; GLUCKMAN E; RIO B; JOUET JP; MICHALLET M; ARCHIMBAUD E; HAROUSSEAU JL; IFRAH N; ATTAL M; GUILHOT F; KUENTZ M; GUYOTAT D; PICO JL; DAURIAC C; LEGROS M; DREYFUS F; BORDIGONI P; LEBLOND V; GRATECOS N; VARET B; AUZANNCAU C; TILLY H; VILMER E; MARANINCHI D
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ADULT WITH ACUTE MYELOID-LEUKEMIA IN 1ST COMPLETE REMISSION - A REPORT FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE

      Blood
    99. FIERE D; LEPAGE E; SEBBAN C; BOUCHEIX C; GISSELBRECHT C; VERNANT JP; VARET B; BROUSTET A; CAHN JY; RIGALHUGUET F; WITZ F; MICHAUX JL; MICHALLET M; REIFFERS J
      ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A MULTICENTRIC RANDOMIZED TRIAL TESTING BONE-MARROW TRANSPLANTATION AS POSTREMISSION THERAPY

      Journal of clinical oncology
    100. PIGNEUX A; REIFFERS J; DEVERGIE A; LAFAGE M; RIO B; ARCHIMBAUD E; CAHN JY; LEBLOND V; MICHALLET M; GUILHOT F; GLUCKMAN E
      RECOMBINANT ALPHA-INTERFERON AS TREATMENT FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Experimental hematology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 19:15:59